Acute upper respiratory tract inflammation
Conditions
Interventions
12 weeks, Active drink, green tea including high catechin concentration three times a day
12 weeks, Active drink, green tea including low catechin concentration, three times a day
12 weeks, C
Sponsors
Department of Drug Evaluation and Information Graduate School of Pharmaceutical Science, University of Shizuoka
Laboratory of Animal Physiology, School of Agriculture, Meiji University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Men and women, high school/university students (2) Able to give written informed consent (3) Able to gargle and to write questionnaire
Exclusion criteria
Exclusion criteria: (1) Potentially having the allergy to green tea (2) Having severe systemic chronic infectious diseases (3) Subjects diagnosed by physicians inappropriate to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 The occurrence of acute upper respiratory tract inflammation. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 The occurrence of influenza 2 The occurrence of SARS COVID-2 3 Term from when clinical trial starts to when acute upper respiratory tract inflammation occurs 4 Adverse events such as pneumonia and encephalopathy or hospitalization | — |
Countries
Japan
Contacts
Public ContactHiroshi Yamada
University of Shizuoka School of Pharmaceutical Sciences
Outcome results
None listed